Hospitals across the country are cutting prices! The third batch was collected and landed

Source: Look at the medical profession (ID: vistamed) after the collection landed drug prices dive! On November 18th, an endocrinologist at Huashan Hospital (North Hospital), affiliated with Fudan University, suddenly disappeared from his prescription of the existing commonly used medicine.
", according to its disclosure, 20, Huashan Hospital General Hospital's Ghua also can not open.
doctors who have had this experience are not just in a hospital in a particular province.
november, doctors in different provinces and cities across the country may have more or less discovered some changes in prescription drugs.
, starting in November, the third batch of national drug collection results have landed, the national medical institutions began to implement, it is understood that the price of selected drugs can be described as a big dive.
It is understood that the results of the third batch of centralized procurement of national drugs was announced on August 25, according to Xinhua News Agency, the collection includes a total of 55 varieties, 125 enterprises, 191 drug regulations, an average price reduction of 53%, the highest decline of more than 95%.
To the above-mentioned doctors mentioned Gwark and Meidling as an example, both drugs are the first-line treatment of diabetes drug metformin, online pharmacy quote information shows that the specifications of 0.5g x 20 tablets of Gwark (Diphthalate tablets hydrochloric acid), the online price is about 29 yuan, the specifications of 0.5g x 30 pieces / bottle of metformin diphthalate slow release tablets, the price range from 28-80 yuan.
And in the third batch of national drug collection catalog, 0.5g x 60 pieces of specifications of metformin hydrochloride tablets, the price is only 3.4 yuan;
public reports show that Dalian City on November 1 at 0:00 in the city's public medical and health institutions to implement the results of the third batch of drugs collection, Quanzhou City, Fujian Province, from November 16 onwards, the third batch of national drug collection and selection of drugs to implement the new price sales; On January 19th, the results of the third batch of national collection were officially implemented in Heilongjiang Province, on November 20th, shanghai implemented the third batch of national collection of drugs, and on November 25th, from 0:00, Shaanxi Province will officially implement the third batch of national collection. A big price cut for drugs sweeping medical institutions across the country has come.
born in the "4 plus 7" national drug collection" drugs are not like drugs, but like stocks; factories to the hospital, poured too many road; hospital dozens of yuan, factory only a few hairs; doctors open what medicine, the key to see money..." "three medical reform practitioners Zhan Yufu used this oil poem sword to refer to the high price of medical reform pain points.
more than 20 years of drug centralized bidding and procurement practice exploration has not effectively solved the problem of high drug prices.
in March 2018, the National Health Insurance Administration was established to take over the burden.
analysts believe that the unreasonable price of drugs is due to decoupling of quantity prices, insufficient competition, procurement diversification and lack of policy synergy, so a higher level of volume procurement is on the agenda.
November 14, 2018, the fifth meeting of the Central Committee for Comprehensive and Deepening Reform deliberated and adopted the Pilot Program for Centralized Procurement of Drugs by National Organizations, which clarified the overall thinking of national organizations, alliance procurement and platform operations.
, with the agreement of the Central Committee for Comprehensive and Deepening Reform, the State organized a pilot project on centralized procurement of medicines in four municipalities directly under the Central Government of Beijing, Tianjin, Shanghai and Chongqing, as well as seven sub-provincial cities in Shenyang, Dalian, Xiamen, Guangzhou, Shenzhen, Chengdu and Xi'an.
December 2018, the prices of the 25 selected varieties in the 4-plus-7 volume procurement pilot were announced, with an average decrease of 52%, with a maximum decline of more than 96%.
9 months later, Shanghai Sunshine Pharmaceutical Procurement Network issued the "Union Regional Drug Purchase Collection Chinese", "Document" pointed out that, on the basis of the results of the 4-7 centralized procurement of national organizations, the relevant regions of the national organization to form alliances, in accordance with the law to carry out cross-regional alliance drug centralized volume procurement.
Alliance Regions: Shanxi, Inner Mongolia, Liaoning, Jilin, Heilongjiang, Jiangsu, Zhejiang, Anhui, Jiangxi, Shandong, Henan, Hubei, Hunan, Guangdong, Guangxi, Hainan, Sichuan, Guizhou, Yunnan, Tibet, Shaanxi, Gansu, Qinghai, Ningxia, Xinjiang (including Xinjiang Production and Construction Corps), except in the Alliance region.
The expansion includes 20 provinces and 5 autonomous regions, plus 4 municipalities directly under the Central Government of 4 plus 7, as well as Fujian and Hebei provinces, which have taken the initiative to follow up the collection earlier, so far, in addition to Hong Kong, Macao and Taiwan, the country's 31 provincial administrative regions are involved in the volume of procurement.
now, the national drug collection has been carried out to the third batch, more than a year, the centralized procurement of drugs organized by the state has also entered the normal operation stage, some falsely high drug prices, is entering the price reduction channel.
high-value medical supplies, injections also came along with the drug national collection continued to advance, high-value medical supplies, injection collection is also advancing.
a training course in June to deepen the reform of the health care system, Hu Jinglin, director of the National Health Insurance Administration, said that centralized procurement will gradually achieve normal operation, policy standardization, standardization of operations and professionalization of the team.
, according to Hu Jinglin, one of the key work in 2020, in addition to the implementation of the results of collection, but also to carry out the national organization of high-value medical supplies centralized procurement.
" in accordance with the governance of high-value medical supplies reform program, this year, we will summarize the previous local procurement experience on the basis of the nationwide organization of high-value medical supplies such as crown stent centralized belt procurement pilot.
", "Thunder" is a character that Hu Jinglin admires, and the National Health Insurance Administration, under Hu Jinglin's leadership, clearly embodies this style.
, the results of the first batch of supplies purchased by the National Health Insurance Administration were announced.
results show that: after this collection, the clinical use of large, high-priced heart stent price fell to the floor price, from the average price of about 13,000 yuan to about 700 yuan.
High-value orthopaedic supplies with the volume of procurement also began to pilot, November 14, covering more than 600 medical institutions in Shandong Province, seven cities procurement alliance part of the medical supplies belt procurement on-site bargaining will be held, this "health insurance negotiations", focusing on high-value medical supplies, covering orthopaedic trauma and hemodialysis two categories, is the first national orthopaedic trauma and hemodialysis city-level alliance with volume procurement.
According to statistics Zibo, Qingdao, Dongying, Binzhou, Texas five cities orthopaedic trauma medical high-value supplies annual use of 30,000, supplies use costs of more than 300 million yuan.
understood that the alliance procurement will cover 7 cities more than 600 medical institutions.
two rounds of negotiations, orthopaedic trauma fell by as much as 94 per cent, or an average of 67.3 per cent.
addition to high-value medical supplies, injection collection is also on the way.
, The Hubei Provincial Health Insurance Bureau issued a notice, announced the implementation rules of the centralized drug belt procurement in Hubei Province, 33 injectable varieties into the first batch of drug collection catalog, mainly penicillin and quinone antibiotics.
the province's public medical institutions (including military medical institutions stationed in the province), medical insurance fixed-point non-public medical institutions will form a procurement alliance "hug group" cut prices.
that the province's first drug collection work will be implemented by Wuhan City, procurement results will be implemented in the province.
cut the price of small craft out of the horse, do not pay for the gray fee! The Health Insurance Bureau in the field of pharmaceutical supplies repeatedly shot soul cut prices, has been nicknamed by the industry as "cut prices small hands."
the future of medical drug prices under the leadership of the Health Insurance Bureau, what trends will be shown? Perhaps you can get a glimpse of what the leadership of the National Health Insurance Administration said at a policy hotspot seminar in Beijing in October 2019.
The leader said: "In the future, the health care sector uphold the trend of strategic purchase and value purchase, not because there is no money to do collection, our values are only buy the right not to buy the gray content, which is also a clear banner to say to the community, health insurance money will not pay for the false high gray cost, money will not pay for the false high gray cost."
including innovative drugs we encourage him to enter the health insurance directory, but you don't do gray fees, we won't pay for it! Zhong Dongbo, director of the pharmaceutical price and tender procurement department of the State Administration of Medical Security, said in an interview with CCTV that the key to the inflated price of drugs now lies in the high cost of sales, with the media revealing that the sales costs of 323 listed pharmaceutical companies reached 287.3 billion yuan in 2019.
", when the price of medicines and medical supplies is inflated, do not rule out a portion of the gray income of doctors, now the water is squeezed out, doctors' pay will also change.
Xu Weicai, a columnist for "Looking at the Medical Profession" and deputy director of the Health and Wellness Bureau in Shanyang County, Shaanxi Province, believes that the collection of drug supplies will affect the income of some medical workers.
to this, the field of health care researchers also believe that the national collection can crack down on gold sales, which may "hurt" some institutions, but also in the process forced pharmaceutical companies to do a good job of innovation.
important task after the big price cuts for medicines and high-value medical supplies is to increase the sun's income for medical personnel.
second, the large price reduction of the selected drugs has a reference effect on the current price and future pricing in the un-selected strip procurement in its therapeutic field, in other words, it may lead to price fluctuations of the unseeded drugs.
third, the price of selected drugs in some volume procurement is clearly lower than a reasonable level, but the adaptive effects of drug treatment persist and sustainability may be a problem.
In Xu's view, after the establishment of the National Health Insurance Administration, in the field of medicine and medicine completed two major events, first completed the negotiations of 17 anti-cancer drugs, and then opened up a shock to the industry's 4 plus 7 belt procurement, and then developed into a centralized procurement of national drug supplies;
Xu Yucai suggested that as hospitals and doctors should hear the sound of the sound of the medical reform horns and the drums of war, proactively make the necessary changes, because "health insurance does not pay for gray expenses" such a declaration, but also a major trend of future changes in the medical sector.